King Saud University
Riyadh, 11433, Saudi Arabia
NCT Number: NCT05201742
Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.
Looking for future studies?
Notify Me65 year–75 year
All sexes
Interventional
Not applicable
Riyadh, 11433, Saudi Arabia
The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Threshold inspiratory muscle training was performed for 6 weeks with device.
Incentive spirometry was performed for 6 weeks with device.
Time frame: 6 weeks
Maximum inspiratory pressure was measured.
Time frame: 6 weeks
Distance walked by the patients in 6 minutes was measured.
Time frame: 6 weeks
Forced vital capacity was measured.
Time frame: 6 weeks
Forced expiratory volume in 1 second was measured
Time frame: 6 weeks
Peak Expiratory Flow Rate was measured
King Saud University
Other
A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06133283
Basal Ganglia Diseases, Brain Diseases
San Antonio, Texas, United States
View Trial DetailsNCT05766813
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07723027
Basal Ganglia Diseases, Brain Diseases
Shakargarh, Punjab Province, Pakistan
View Trial DetailsNCT07361250
Basal Ganglia Diseases, Brain Diseases
Wuhan, Hubei, China
View Trial Details